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Abstract 
D-amino acids endow peptides with diverse, desirable properties, but the post-translational and site-
specific epimerization of L-amino acids into their D-counterparts is rare and very challenging. 
Bottromycins are ribosomally synthesized and post-translationally modified peptides that have 
overcome this challenge and feature a D-aspartate (D-Asp), which was previously proposed to arise 
spontaneously during biosynthesis. We have identified the highly unusual alpha/beta-hydrolase (ABH) 
fold enzyme BotH as a novel peptide epimerase responsible for the post-translational epimerization of 
L-Asp to D-Asp during bottromycin biosynthesis. To understand the mechanism of this reaction, we 
determined the structures of BotH and the BotH-substrate complex. We also found BotH to bind the 
natural product itself, which has implications for the regulation of bottromycin biosynthesis. 
Bioinformatic analyses of BotH homologs show that similar ABH enzymes are found in diverse 
biosynthetic gene clusters. 
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Introduction 
Enzymes belonging to the superfamily of alpha/beta-hydrolase-fold proteins (ABHs) are found in all 
domains of life1-3. Their catalytic roles are highly diverse and they participate in primary and 
secondary metabolism, where they are usually responsible for the hydrolysis of (thio)ester and peptide 
bonds4. In addition, ABHs have also been reported to function as dehalogenases, epoxide hydrolases, 
dioxygenases, decarboxylases and haloperoxidases3,4. Despite low overall sequence conservation, 
ABH enzymes share a remarkably conserved core fold2,3 that has a V-shaped lid domain above the 
active-site as a frequent addition5,6. A majority of ABH family members possesses a canonical Ser, 
His, Asp catalytic triad at the active-site, but other catalytic residues have also been observed3,4. In 
addition to catalytic roles, a ABH family members have also been reported to fulfil several other 
important functions, including small-molecule receptors that are involved in signal transduction, cell-
cell interaction and channel regulation5-8. The ABH fold is thus a prime example for the 
reappropriation of a conserved core fold during evolution to fulfill a myriad of functions. 
An aberrant ABH protein, BotH, is encoded in the biosynthetic gene cluster (BGC) for bottromycins9-
12. This natural product family was first isolated from the terrestrial bacterium Streptomyces 
bottropensis and originally described as peptidic antibiotics with potent activity against Gram-positive 
bacteria13,14. Bottromycins are active against problematic human pathogens, such as Methicillin-
resistant Staphylococcus aureus15,16, address a novel target (the A-site of the prokaryotic ribosome)17-19 
and belong to the fast growing superfamily of ribosomally synthesized and post-translationally 
modified peptides (RiPPs)9-12. As is typical for RiPPs, their biosynthesis begins with the expression of 
a small structural gene to yield the precursor peptide (PP)20. Uniquely amongst bacterial RiPPs, the 
bottromycin PP contains an N-terminal core peptide (the eventual natural product) and a C-terminal 
follower peptide9-12, which is important for substrate recognition by several of the biosynthetic 
enzymes21,22. The order of biosynthetic steps (and responsible enzymes) has since been proposed based 
on an untargeted metabolomics approach using mass spectral networking23. Subsequent in vitro work 
has largely corroborated the metabolomics data21,22,24,25. In the first phase of bottromycin biosynthesis, 
the N-terminal methionine is removed, proline, valine and phenylalanine residues of the core peptide 
are C-methylated and a cysteine-derived thiazoline is installed in no particular order23. The hallmark 
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macroamidine linkage is then formed in this intermediate21,22, which is followed by proteolytic 
removal of the follower peptide to yield 1 (Figure 1A)25. 
 
Figure 1: A Bottromycin BGC found in S. sp. BC16019. After expression of the precursor peptide 
BotA, its N-terminal methionine is removed by BotP, three radical methyl transferases (RMT) perform 
four C-methylations and BotC installs a cysteine-derive thiazoline. These initial steps appear to follow 
no particular order. Next, BotCD catalyzes formation of the macroamidine, after which BotAH 
removes the follower peptide to yield 1. Oxidative decarboxylation (BotCYP) and O-methylation 
complete the biosynthesis of bottromycin A2 (2). Epimerization was proposed to occur spontaneously. 
Genes, enzymes and modifications have matching colors. White arrows represent genes for which no 
or a regulatory function have been proposed. The unusual ABH protein encoded in the pathway, BotH, 
is highlighted in pink. B Epimerization in RiPP biosynthesis reported to date. In proteusins, including 
polytheonamides, and epipeptides a radical SAM enzyme epimerizes a range of amino acids. In 
lanthipeptide biosynthesis, L-Ser can be converted to D-Ala in a two-step process. 
 
To complete the biosynthesis of bottromycin A2 (2, Figure 1A), 1 undergoes epimerization, oxidative 
decarboxylation and O-methylation. While the latter two modifications have been attributed to specific 
enzymes, epimerization of the L-Asp of 1 was observed to progress spontaneously, albeit very 
slowly23. 
Amino acid epimerization in non-ribosomal peptide synthesis is usually catalyzed by epimerization 
domains embedded within the assembly line that function on carrier protein-bound aminoacyl 
substrates26. Due to their ribosomal origin, RiPPs must undergo post-translational epimerization after 
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the PP has been expressed as an all L-amino acid peptide. To date, only two enzymatic mechanisms 
for this process have been described in RiPPs, involving either a radical-SAM enzyme27-30 or a two-
step dehydration-hydrogenation process to generate D-alanine from L-serine31,32. 
Here, we report the identification of BotH, an unusual ABH enzyme from the bottromycin BGC, as 
the epimerase of the biosynthetic pathway. This is the first reported instance of an ABH enzyme 
catalyzing peptide epimerization and thus expands the catalytic scope of this vast enzyme family. 
Biochemical data together with the structure of the BotH–substrate complex allowed us to propose a 
mechanism for this reaction. Interestingly, BotH is also able to bind bottromycins with high affinity, 
which hints at additional function(s) in the biosynthetic process. We show that all canonical ABH 
active-site residues required for hydrolase activity are absent in BotH, and bioinformatic analyses 
indicate that BotH homologs with comparable non-hydrolytic residues are widespread amongst BGCs 
and may catalyze similar biosynthetic steps. 
 
Results and Discussion 
BotH is an unusual member of the ABH superfamily 
In a search for an enzyme that may catalyze the epimerization in the bottromycin pathway, we noticed 
that the gene encoding for BotH had been annotated as an ABH, but that the predicted active-site 
residues (Ser/His/Asp) were not present and there were no prior experimental data on the role of this 
protein. We therefore expressed, purified and crystallized BotH (see Materials and Methods for 
details). A high-resolution (1.18 Å) native BotH dataset was collected from a crystal belonging to 
space group I222, which was phased using seleno-methionine BotH data (data collection and 
refinement statistics for all structures can be found in Table S1). The crystals contained one protomer 
in the asymmetric unit and the electron density for residues 10 – 262 was continuous in the refined 
model. BotH is comprised of the prototypical ABH core structure (Figure S1) and the putative active 
site was covered by a V-shaped loop consisting of four -helices (Figure S1). A search for similar 
structures using the DALI server33 revealed 3-oxoadipate-enol-lactonase (PDB 2xua)34 as the closest 
structural homolog (Figure S1). A comparison of the two proteins revealed that in BotH, the active-site 
Ser has been mutated to a Phe, which is part of a Phe-Phe motif that spans a large, hydrophobic plane 
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at the active site (Figure S1). The remaining residues of the catalytic triad are either mutated (His to 
Ile) or missing (Asp) (Figure S1). In spite of these mutations, the sizeable cavity found in this region 
of the structure appeared to be large enough for binding 1. 
 
BotH catalyzes the epimerization of 3b and 3a 
To confirm this hypothesis, a des-methyl analog of 1, 3 (des-methyl Pro2, Val4, Val5 and Phe6), was 
enzymatically produced as reported previously (Figures 2A and S2)25. Careful analysis revealed 3 to 
exist as an epimeric mixture of 3a (D-Asp) and 3b (L-Asp) (Figures 2A and S3 – S5). When 20 µM 
3a/b was incubated with 5 µM BotH and the reactions were analyzed by high-resolution electrospray 
ionization liquid chromatography−mass spectrometry (HR-ESI-LCMS), we observed a change in 3a : 
3b ratios (Figure 2B), which was BotH-concentration dependent within the 2 h time-scale of the 
experiment (Figure 2C): Increasing the BotH concentration resulted in a shift to 3a (D-Asp), which is 
the required epimer to proceed with biosynthesis35. To probe if only 3b or both epimers were 
substrates, we incubated 3a/b with BotH in D2O. This resulted in rapid (< 60 s) deuteron incorporation 
at the Asp7 position in both peaks, while very little deuteron incorporation was observed in the 
absence of BotH even after 24 hours (Figures 2D, S4 and S6). In fact, BotH concentrations low 
enough to leave epimer ratios unchanged still resulted in accelerated deuteron incorporation (Figure 
S6). Repeating this experiment using the deuterated sample in H2O showed an equally rapid exchange 
with solvent protons back to 3a/b (Figure S6). These data implied that BotH accepts both, 3a and 3b, 
as substrates in a reversible reaction, while favoring D-Asp (3a) as the product. 
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Figure 2: A Spontaneous epimerization of the Asp in position 7 after proteolytic removal of the 
follower peptide. Marfey’s reagent was used to assign the stereochemistry of the Asp for both peaks 
(Figure S5). Extracted ion chromatograms (EIC) of 3 (M+H+calc.=799.3807;  5 ppm) and mass 
spectra at 3.00 and 3.15 min are shown. Missing methyl groups are highlighted by dashed ovals. B 
Incubation of 3a/b with BotH results in a change of 3a : 3b ratios with 3a (D-Asp) now the more 
abundant species. EICs of 3 (M+H+calc.=799.3807;  5 ppm) are shown. C Incubating 20 µM 3a/b 
with increasing concentrations of BotH led to a shift of the equilibrium towards 3a. Increasing BotH 
concentrations beyond 10 µM did not lead to a further shift of epimer ratios. EICs of 3 
(M+H+calc.=799.3807;  5 ppm) are shown. D Deuteron incorporation into 3a/b by BotH in D2O 
buffer. EICs for 3 (M+H+calc.=799.3807;  5 ppm) (black) and deuterium incorporated 3 
(M+H+calc.=800.3870;  5 ppm) (red), as well as mass spectra at the EIC maxima are shown. 
Representative experiments were repeated independently three times with similar results. 
 
Structure of the BotH-3a complex 
To better understand the mechanism of this intriguing enzyme, the high-resolution crystal structure of 
BotH in complex with its substrate 3a/b was determined to 1.25 Å resolution. The overall structure of 
the complex was virtually unchanged when compared to the apo structure (C rmsd of 0.12 Å) (Figure 
S7). The substrate is curled into the active site in a way that places the thiazoline underneath the four 
amino acid macrocycle and the substrate engages in extensive hydrophobic interactions as well as 
inter- and intramolecular hydrogen bonds (Figures 3A and S7). Of particular note are hydrogen bonds 
of the thiazoline carboxy group with the backbone NH of Val41 and Phe110. These two BotH residues 
are in the position of the oxyanion hole found in many hydrolases. The carboxy group of the 
substrate’s Asp7 is involved in a hydrogen bonding network with ordered water molecules that 
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ultimately link this side-chain to BotH residues (Figure S7). An intramolecular hydrogen bond links 
the substrate’s carbonyl of Val3 with the backbone NH of Asp7. The best fit to the electron density is 
achieved by choosing the amidine resonance structure that places the double-bond inside the 
macrocycle and a D-Asp in position 7, which indicates that the ligand observed in the complex 
structure is 3a (Figure S7). Since the epimerization mechanism would, at least formally, involve 
proton abstraction and addition, we scanned the complex structure for potential catalytic residues 
within 4 Å of the C hydrogen of Asp7, the site of catalysis, but could not identify any. This left two 
possibilities: bulk solvent or the side chain of substrate Asp7; its carboxy group is within 2.2 Å of the 
C hydrogen of interest. To probe the importance of the side chain identity in position seven for 
epimerization, we first tested the conservative mutant substrates Asp7Ala and Asp7Asn. While both 
substrates stabilized BotH in thermal shift assays comparable to 3a/b, we observed no epimerization 
(Figure S8). The extension of the Asp7 side-chain by an additional methylene group (Asp7Glu), 
results in severely reduced turnover by BotH, but this substrate epimerizes (Figure S8). These data 
imply that a side-chain carboxy group in position 7 of the substrate is essential for catalysis and that 
the appropriate distance of this carboxy group relative to the residue’s C proton has a significant 
impact on turnover, which suggests that the BotH reaction may be an example of substrate-assisted 
catalysis. 
 
BotH has relaxed substrate specificity 
We had previously reported that the enzymes used to generate 3a/b possess relaxed substrate 
specificities for core-peptide residues 2 – 7 (Figure S9)25. Since substrate position 7 was restricted to 
Asp or Glu for epimerization, we wondered if BotH tolerates mutations in the remaining positions. To 
this end, a series of 13 BotA core-peptide mutants were used to produce the variant BotH substrates 
enzymatically. These substrates were then incubated with or without BotH and analyzed by LC-MS 
(Figures 3B and S10 - 11). All but two mutations in positions two to six were processed by BotH. The 
positions of Val5 and Phe6 are intimately connected and it appeared that the orientation of the Phe6 
side-chain is critical for epimerization. In agreement with this hypothesis, Phe6Ala could not be 
epimerized by BotH while Phe6Tyr and Phe6Trp were substrates. The side-chain of position 5 (Val) is 
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engaged in hydrophobic interactions with the side-chains of Val4 and Phe6. Accordingly, Val5Thr is 
not a BotH substrate, while Val5Ala, Val5Leu and Val5Glu can be epimerized by the enzyme. The 
ability of BotH to process Val5Glu may appear surprising, but the flexibility of the Glu side chain 
should allow the C methylene of Glu5 to engage in hydrophobic interactions with Val4 and Phe6, 
while the C methylene and terminal carboxy group point towards bulk solvent. Our data demonstrate 
that BotH is able to process a variety of substrates, which will be invaluable for the production of 
bottromycin derivatives. 
 
Figure 3: A Close-up of 3a (gray sticks, labeled. Tzn = Thiazoline) bound in the BotH active site 
(cartoon, yellow/magenta with semi-transparent surface representation). The ordered water molecule 
trapped between substrate and protein is shown as a red sphere. The Asp7 C hydrogen is shown as a 
white stick for clarity. B Summary of BotA point mutants tested as BotH substrates. Purple positions 
cannot be varied (pentagon represents thiazoline). Accepted mutations are highlighted in green, orange 
indicates a poor substrate and red mutations cannot be processed by BotH. The accompanying HR-
LCMS data can be found in Figures S10 – S11. C Same as A, but bottromycin A2 (dark gray sticks, 
labeled) bound to the active site of BotH. m = methylated residue, Om = O-methylated residue, Thz = 
Thiazole. D Sequence similarity network of ABHs homologous to BotH (marked with an asterix). Of 
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the 107 genes, 76 could be assigned to BGCs representing the three large bacterial natural product 
superfamilies (darker edges represent higher sequence similarity, NRPS = non-ribosomal peptide 
synthetase; PKS = polyketide synthase). 
 
BotH binds bottromycins, which act as inhibitors of epimerization 
Since 3a/b are close structural homologs of bottromycin A2 (2), it seemed feasible that BotH may be 
able to bind to bottromycins. We thus performed microscale thermophoresis (MST) experiments using 
heterologously produced 2 and three closely related variants (4 – 6, Figure S12). BotH was able to 
bind all four bottromycins with KD values in the high nM to low µM range but unable to epimerize 
oxidatively decarboxylated 3a (Figure S12). To understand the mode of binding, we determined the 
crystal structures of three bottromycin–BotH complexes to 1.40 (2), 1.70 (5), and 1.48 (6) Å 
resolution, respectively (Figures 3C and S13 – 14). These also represent the first crystal structures of 
any bottromycin. As observed for the complex with 3a, the overall structural change in BotH due to 
ligand binding was minimal (C RMSD < 0.2 Å) and the bottromycins bound in a similar manner as 
3a (Figures 3A and 3C). Despite the high resolution, it is not obvious which way the thiazole is 
flipped, since the loss of the carboxy group due to thiazoline oxidation allows a fit of both rotamers 
without inducing a clash with BotH (Figure S15). The bottromycins themselves are oriented in a 
twisted fashion that results in several tight, intramolecular hydrogen bonds (Figure S14). Compared to 
the published NMR structure36, bottromycin A2 experiences significant strain as a result of binding to 
BotH, as it is forced to adopt a horseshoe shape with Val5 and Phe6 at its apex and the C-terminal 
thiazole stacked parallel under the macrocycle (Figure S16). As expected, bottromycin A2 acts as an 
orthosteric inhibitor of epimerization (Figure S17), which suggests that BotH may be involved in a 
biosynthetic feedback mechanism to prevent self-poisoning of the producing strain (Figure 4A). 
In this model, an increase in the intracellular bottromycin concentrations offers a direct and faster 
means to reduce bottromycin production than altered gene expression since epimerization of Asp7 is 
highly important for the activity of the succeeding enzyme BotCYP35. It is of course also possible that 
BotH sequesters mature bottromycin to aid self-immunity. 
The ability of BotH to bind both the substrate and the mature natural product with high affinity may 
serve as a cautionary tale for attempting to identify the binding partners of “non-catalytic” ABHs. 
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When using BotH to capture its ligand/substrate from either supernatant or lysate of a bottromycin 
producing strain, we were only able to detect bottromycin A2, but not the actual substrate 1 (Figure 
S18). Since biosynthetic pathway products tend to be present at higher concentrations than pathway 
intermediates, careful analysis of the biosynthetic pathway supplying the ligand is required to exclude 
additional, non-canonical catalytic function(s) of the ABH under investigation. 
 
Evolution of BotH and its distribution amongst bacterial BGCs 
ABHs comprise one of the largest protein families (~500,000 protein matches in InterPro37, ~400,000 
of them in Bacteria), of which 192,602 belong to Pfam38 family PF00561 (Abhydrolase_1). The Ser-
His-Asp catalytic triad is surprisingly poorly conserved: in 101,123 bacterial proteins from the 
PF00561 family, at least one of the catalytic residues is mutated or missing. In most cases (73,116 
sequences), His is missing; and in the majority of these proteins (64,852 sequences) Asp is missing as 
well. Ser is mutated in only 42,810 sequences, most frequently to an aspartic acid, and completely 
missing in 1,283 sequences. Using these data, we identified 1,530 proteins that are unlikely to have 
hydrolase activity (see Materials and Methods section for details), including BotH. Taxonomic 
analysis revealed that these non-functional hydrolases are widespread among both Gram-positive and 
Gram-negative bacteria. 
From these sequences, we then selected those that were in or near (less than 1 kb away) BGCs, which 
resulted in 107 proteins that were used to build a sequence–similarity network (Figures 3D and S19). 
In this network, all BotH homologs from bottromycin BGCs cluster together. Among the identified 
BGCs, two other major natural product superfamilies can be identified in addition to RiPPs: NRPS 
(non-ribosomal peptide synthetase) and PKS (polyketide synthase) clusters. 
 
Conclusion 
We have identified the enzyme BotH as the epimerase of the bottromycin BGC, which is selective for 
Asp and Glu, but promiscuous with regards to mutations at other positions of the substrate. Based on 
the biochemical and structural data, we propose the following mechanism for epimerization in 
bottromycin biosynthesis (Figure 4B): Cleavage of the follower peptide converts the 2-thiazoline 
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residue into a 2-thiazoline-4-carboxy moiety at the carboxy terminus of 3b, which is bound by BotH. 
Interestingly, the two BotH residues that form hydrogen bonds with the thiazoline carboxy group are 
in the position of the canonical oxyanion hole found in most ABHs. By binding, 3b traps an ordered 
water molecule within hydrogen-bonding distance of the thiazoline’s nitrogen and carboxy group. The 
side-chain of Asp7 is positioned such that it may serve as a base to abstract the C proton from itself, 
which triggers enamine formation and leads to proton transfer from the ordered water molecule to the 
thiazoline nitrogen. The resulting hydroxide is still hydrogen bonded to the thiazoline’s carboxy group 
and the thiazoline nitrogen proton. Abstraction of this proton by the hydroxide triggers reprotonation 
of the enamine by the side chain of Asp7 and results in epimerization. The inability of BotH to 
epimerize substrate with an Asp7Asn mutation suggests an essential role of the carboxylic acid side 
chain and thus substrate-assisted catalysis. As demonstrated by our hydrogen-deuterium-hydrogen 
exchange experiments, this reaction is fully reversible. We would like to note that the carboxy group 
of Asp7 is surrounded closely (O – O distances 2.5 – 3.1 Å) by four ordered water molecules (Figure 
S20), which appear well-positioned to facilitate the exchange of the abstracted proton/deuteron with 
bulk solvent during catalysis (Figure S20). It appears that lowering of the energetic barrier for 
epimerization by BotH is sufficient to supply the succeeding enzyme with sufficient substrate for 
complete turnover, even without changing the 3a : 3b ratios35. This situation is reminiscent of non-
ribosomal peptide synthetases that can contain epimerase domains, which produce a mixture of D- and 
L-epimers of a particular amino acid. The succeeding enzyme (condensation domain) then provides the 
stereochemical resolution of the pathway through selective incorporation of the D-amino acid39. 
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Figure 4: A Proposed role of BotH in bottromycin biosynthesis. A rise of intracellular bottromycin 
concentrations leads to an inhibition of BotH epimerase activity, which may in turn prevent self-
poisoning of the producing strain and act as an intracellular buffer to store bottromycins. B Proposed 
mechanism for the epimerization of 3b to yield 3a. BotH residues are labeled in black, substrate 
residues in blue. Hydrogen bonds are shown as dashed lines. Ordered water molecules surrounding the 
Asp7 carboxy group are not shown for clarity (see Figure S20 for details). 
 
It is still unclear why bottromycin A2 contains a D-Asp, as studies with synthetic derivatives have 
shown that both epimers display the same bioactivity40. Selectivity of the bottromycin exporter BotT 
appears possible, despite a very small fraction of bottromycin A2 in culture supernatant appearing to 
be the L-Asp epimer (Figure S21). The main benefit of epimerization may be providing increased 
resistance to proteolytic degradation of bottromycin, since D-amino acid containing peptides have 
longer half-lives41,42. It is of course also possible that the bottromycin target of organisms in a native 
setting requires a D-Asp for optimal target binding. Interestingly, the structure elucidation of novel 
bottromycin analogs via crystallization of their complex with BotH appears to require less compound 
and be more straightforward than NMR, due to the robust crystallization condition, high affinity and 
very well-diffracting crystals. 
The presence of BotH-like ABH protein encoding genes in over 100 BGCs encoding for the 
biosynthesis of diverse secondary metabolites places BotH as the founding member of a new 
subfamily of non-classical ABH enzymes. It will be fascinating to explore the functions of selected 
homologs, which may be able to epimerize non-Asp stereocenters across families of secondary 
metabolites via the unprecedented mechanism we have identified for bottromycin. 
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Methods 
Protein expression and purification 
The BotH coding sequence was amplified from genomic DNA isolated from Streptomyces sp. 
BC16019 and cloned into the pET-28b plasmid (Novagen). The resulting construct was verified by 
enzymatic restriction digestion and DNA sequencing before being transformed into E. coli BL21(DE3) 
competent cells. 
A single colony was selected and grown in LB liquid medium supplemented with kanamycin (50 μg / 
mL) to make an overnight culture. This culture was used at a dilution of 1 to 100 to inoculate fresh LB 
medium containing the appropriate antibiotic, and the culture was grown at 37 °C, 180 rpm. Upon 
reaching an optical density (OD600) of 0.6, the cultures were transferred to a precooled shaker at 16 °C, 
and protein expression was induced by addition of 1 mM IPTG. The cells were grown at 16 °C and 
180 rpm over night before being harvested by centrifugation. Cell pellets were stored at -80 °C until 
further use. 
The cell pellets were resuspended in lysis buffer (20 mM Tris pH 8.0, 500 mM NaCl, 20 mM 
Imidazole, and 3 mM DTT) supplemented with 0.4 mg DNAse per gram of wet cell pellet and 
cOmplete EDTA-free protease inhibitor tablets (Roche). The cell suspension was lysed via passage 
through a cell disrupter (Constant Systems) at 30,000 psi, and cell debris was removed by 
centrifugation (40,000 x g, 4 °C, 15 min). The supernatant was collected and directly loaded onto to a 
5 mL Histrap HP column (GE healthcare) preequilibrated with lysis buffer. The column was washed 
extensively with lysis buffer (30 CV) before the protein was eluted with lysis buffer supplemented 
with 250 mM imidazole. Fractions containing BotH were directly loaded onto a gel filtration column 
(HiLoad 16/600 Superdex 200 pg, GE healthcare) preequilibrated in gel filtration buffer A (20 mM 
HEPES pH 7.4, 200 mM NaCl, 1 mM TCEP). The fractions of the highest purity as judged by SDS-
PAGE were pooled and concentrated to 5 mg / mL. 
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Crystallization and structure determination 
For crystallization, BotH was treated with thermolysin (1 : 100) on ice for 2 h, after which the protein 
was passed over a HiLoad 16/600 Superdex 200 pg gel filtration column as described above and 
concentrated to 5 mg / mL. Crystals of apo BotH and BotH in complex with ligands were obtained at 
18 °C in 1.2 - 1.8 M ammonium sulfate and 0.1 M Tris-HCl using the hanging drop vapor diffusion 
method. For the complex crystallization, the thermolysin-treated protein was incubated with excess 
ligand (1 - 2 mM) on ice overnight before setting up crystallization drops. Crystals appeared after a 
few days and were allowed to grow for an additional week. The crystals were cryoprotected in mother 
liquor supplemented with 30% glycerol and 0.5 mM ligand. Data was collected at ESRF (Beamlines 
ID23-1 and ID23-2), DESY (Beamline P11) and SLS (Beamline X06DA). To solve the apo structure, 
a single wavelength anomalous dispersion (SAD) data set was collected at the Se K absorption edge. 
Data were processed using Xia243, the structure was solved using PHENIX AutoSol44 and the initial 
model used to obtain a molecular replacement solution for the high-resolution native data set using 
Phaser45. The solution was manually rebuilt in COOT46 and refined using PHENIX Refine44. This apo 
structure was then used as a search model for structure determination of the complex crystal structures 
by molecular replacement (Phaser). Data for all complex crystal structures were processed using 
XDS47 and POINTLESS48, AIMLESS49 and Ctruncate50 implemented in ccp451. All structures were 
validated using MolProbity. The images presented were created using PyMOL (Schrödinger, LLC) 
and LigPlot+52. 
 
Enzymatic reaction of BotH with 3 
To investigate the effect of BotH on 3a/b, 20 µM 3a/b were incubated with and without the addition 
of 5 µM BotH in GF buffer for 30 min. Reactions were stopped by the addition of 2 volumes ACN and 
were frozen at -80 °C until analysis. Reactions were set up and analyzed in at least triplicates.    
To test the effect of different BotH concentrations on the 3a : 3b ratio, 20 µM 3a/b were incubated 
with 0, 0.37, 1.11, 3.33 or 10 µM BotH at 30 °C for 2 h in GF buffer. Reactions were stopped by the 
addition of 2 volumes ACN and were frozen at -80 °C until analysis. Higher concentrations than 
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10 µM or longer incubation times were also tested, but did not lead to a further shift of epimer ratios. 
Reactions were set up and analyzed in triplicates.  
To produce a roughly racemic mixture of 3a : 3b, 20 µM 3a/b were incubated with 4 µM BotH for 
30 min at 30 °C in GF buffer. BotH was denatured at 98 °C, 10 min, pelleted by centrifugation 
(15 min, 15,000 rpm) and the supernatant was lyophilized to remove all solvent. 
 
Data availability 
Atomic coordinates and structure factors have been deposited in the RCSB Protein Data Bank with 
accession codes 6T6H (BotH apo), 6T6X (BotH-3a complex), 6T6Y (BotH-2 complex), 6T6Z (BotH-
5 complex), and 6T70 (BotH-6 complex). Other relevant data supporting the findings of this study are 
available in this published article, its Supplementary Information files or from the corresponding 
author upon request. 
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